Developer docs
API playgroundTry for free, no card

Search company profiles

Avrio MedTech

Full company profile

uuid02m24bs

Namestring
Avrio MedTech
Legal namestring
SAS Avrio MedTech
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Avrio MedTech is a French deeptech company founded in August 2023 in Toulouse, commercializing Halyzia®, a software platform for advanced visualization and quantitative analysis of intracranial EEG (iEEG/SEEG) data. The product is built on more than a decade of academic research conducted at CerCo (CNRS), CHU Toulouse, and ENAC, and integrates signal processing, artificial intelligence, and visual analytics to detect epileptic biomarkers — including spikes, ripples (80-200 Hz), and fast ripples (200-600 Hz) — and to compute the Epileptogenicity Index for seizure onset analysis. A core technical differentiator is the patented WALFRID wavelet-based CNN detector for fast-ripples, held under exclusive worldwide rights (PCT/EP2022/079304, US 2024/0398319 A1). Halyzia supports micro/macro electrode recordings up to 32 KHz and combines automatic detection with expert validation workflows and topographic brain mapping.

The company monetizes through three streams: software licensing (subscription/recurring) of Halyzia to research institutions, hospitals and clinics; professional services including quantitative iEEG analysis, custom Clinical Decision Support System development, protocol writing, and project management; and technology integration / white-label modules for EEG equipment providers. Go-to-market combines product-led growth via a free trial download from the website, direct enterprise sales for hospitals and therapeutic innovators, and a channel partnership with FHC Inc. announced in January/February 2025. Customer segments are verticalized: researchers and clinicians (primary), therapeutic innovators (drug developers, neuromodulation, thermo-coagulation), and EEG equipment providers. Named customers and partners include NYU Grossman School of Medicine, CHU de Toulouse, Grenoble University Hospital, CerCo (CNRS), Hôpital Fondation Adolphe de Rothschild, and FHC Inc.

Avrio is a privately held SAS (Société par Actions Simplifiée) with SIREN 978328037, headquartered at the B612 innovation center in Toulouse Aerospace, with an approximately 10-person multidisciplinary team led by co-founders Karine Seymour (CEO, ex-founder of Medexprim), Emmanuel Barbeau (Clinical Lead, CNRS Director of Research), and Christophe Hurter (Data Science Lead, ENAC Professor). To date, funding has been exclusively non-dilutive — Bourse French Tech Emergence (BPI France, 2023), CREALIA Occitanie (2023), DESIRE Eurocluster (2024), and a €75,000 Women TechEU award (January 2025) — with no disclosed institutional venture capital or external revenue figures.

Short descriptiontext

Avrio MedTech is a French deeptech company commercializing Halyzia®, an AI-powered intracranial EEG visualization and analysis platform for epilepsy research and clinical decision support, serving academic medical centers, hospitals, therapeutic innovators, and EEG equipment providers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersToulouse, France
HQ citystring
Toulouse
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
intracranial EEG software, epilepsy biomarker analysis, neuroscience visualization tools, SEEG data analysis, medical signal processing
Industry3 codes
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAKAIAB
Epilepsy & Seizure Disorders
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Neurodiagnostic Software
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Software Licensing
TypeSubscription Recurring
Description

Halyzia® software licenses sold to research institutions, hospitals, and clinics. Available for research-use only. Contact-based pricing model.

avriomedtech.com
2Professional Services
TypeProfessional Services
Description

Quantitative analysis as a service, custom software development, project management, protocol writing, and clinical site contracting services for iEEG research projects.

avriomedtech.com
3Technology Integration/White-label
TypeLicensing Royalties
Description

Ready-to-integrate modules for EEG equipment providers and therapeutic innovators. Custom development and white-label options available.

avriomedtech.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Free Trial - Research evaluation license
ModelFreemiumBilling cadencePay-as-you-go
Notes

Temporary license granted free of charge for evaluation purposes only, excluding clinical use. Valid until defined period indicated in download page.

avriomedtech.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Halyzia®
Description

Next generation software for advanced review and quantification of intracranial EEG (iEEG) data. Built on more than 10 years of academic research, Halyzia® integrates advanced signal processing, artificial intelligence, advanced visual analytics, and scalable performance for massive datasets. Features include automatic detection of epileptic spikes and high-frequency oscillations (HFOs), seizure onset analysis with Epileptogenicity Index, and topographic mapping capabilities.

avriomedtech.com
Core offering1 text field

Avrio MedTech develops and sells Halyzia®, a software platform for advanced review and quantitative analysis of intracranial EEG (iEEG/SEEG) recordings. The software combines signal processing, artificial intelligence, and visual analytics to automatically detect epileptic biomarkers (spikes, ripples, fast ripples) and compute the Epileptogenicity Index for seizure onset analysis. It also offers quantitative iEEG analysis services, custom clinical decision support system development, white-label ready-to-integrate modules for EEG equipment providers, and project management services for epilepsy research projects.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 55% of patients remain seizure-free 5 years after epilepsy surgery when analysis enables surgical decision
+1 more record
Product overview1 text field

Avrio MedTech offers Halyzia as its core unified software platform for intracranial EEG (iEEG) quantitative analysis in epilepsy research. The product portfolio includes Halyzia (the main software product), supplemented by professional services such as quantitative iEEG analysis services, custom CDSS development, white-label ready-to-integrate modules for EEG equipment providers, and project management services. The software integrates advanced signal processing, AI-based biomarker detection, and interactive visualization tools.

Product and service5 records
1Halyzia®
CategoryCore Software Product
Description

A next-generation intracranial EEG (iEEG) visualization and quantification software for advanced review and quantitative analysis of iEEG data. Halyzia enables automatic detection of epileptic biomarkers (spikes, ripples, fast ripples) and seizure onset analysis using the Epileptogenicity Index, with interactive topographic brain mapping. Built on more than 10 years of academic research and integrating advanced signal processing, AI, visual analytics, and scalable performance for massive datasets including micro-electrode recordings at up to 32 KHz. Available for research-use only.

2Quantitative iEEG Analysis Services
CategoryProfessional Services
Description

Expert services including custom iEEG processing pipelines, advanced biomarker extraction, study design and protocol support, data analysis and reporting, and software development and system integration. Services support the full lifecycle from exploratory research to large-scale multicenter studies.

3Clinical Decision Support System (CDSS) Custom Development
CategoryProfessional Services
Description

Custom design and development services for building dedicated Clinical Decision Support Systems for therapeutic innovations. Integrates clinical, imaging, and electrophysiological data with automated pipelines and intuitive interfaces.

4Ready-to-Integrate Modules (White-label)
CategoryLicensing / Integration
Description

White-label modules for EEG equipment providers offering review and monitoring software in iEEG epilepsy monitoring units, enabling advanced analytics capabilities to be embedded in third-party offerings.

5Project Management Services
CategoryProfessional Services
Description

Comprehensive project management including writing research protocols, sourcing data, contracting with clinical sites, analyzing results, and writing papers for studies involving iEEG signals.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-01-31
Description

Avrio MedTech and FHC Inc. announced a partnership for distribution of Avrio's innovative sEEG analysis software, Halyzia. FHC integrates Halyzia into their portfolio, providing customers with powerful, modern analytical software alongside their world-class EEG hardware. This partnership extends market reach to epileptic monitoring units globally.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

MICROMED (now part of Bittium) provides EEG acquisition and analysis software used in clinical and research settings. It competes with Halyzia in the intracranial and scalp EEG review/quantification market.

TypeDirect peer
Description

BESA provides source localization and EEG/MEG analysis software widely used in epilepsy research and clinical neurology. It is comparable to Halyzia as a specialized EEG analysis platform for neuroscience and clinical use.

TypeDirect peer
Description

ANT Neuro provides EEG and MEG acquisition systems plus analysis software used in neuroscience and clinical applications. It competes with Avrio MedTech in the EEG analysis software category.

TypeDirect peer
Description

Blackrock Microsystems manufactures neural recording hardware and offers analysis tools used in intracranial EEG research. It is comparable to Avrio MedTech as a provider serving the iEEG research and clinical neuroscience market.

TypeEmerging player
Description

g.tec develops brain-computer interface and EEG analysis tools, including real-time signal processing. It overlaps with Halyzia in advanced EEG analysis, with a stronger BCI orientation.

TypeEmerging player
Description

Wave Neuroscience applies EEG-based analytics for neurological and psychiatric conditions. It is an emerging player with adjacent, partially overlapping capabilities to Halyzia's quantitative EEG/biomarker focus.

TypeDirect peer
Description

Compumedics offers EEG systems including the Curry analysis suite used in clinical epilepsy workflows. It is comparable to Avrio MedTech in serving epilepsy monitoring units with quantitative EEG tools.

TypeBroad incumbent
Description

Natus Medical is a broad incumbent in neurodiagnostics, offering EEG, EMG, and ICU monitoring hardware plus software (including the Persyst acquisition). It is comparable to Avrio MedTech as an established player whose portfolio overlaps with Halyzia's analytics focus.

TypeDirect peer
Description

Persyst develops automated EEG analysis software (seizure detection, trending, spike detection) used widely in clinical neurology. It is a direct competitor to Halyzia's automated detection capabilities and is now part of Natus Medical.

TypeDirect peer
Description

Brain Products manufactures EEG hardware and offers BrainVision Analyzer for EEG review. It is comparable to Avrio MedTech in the combined EEG hardware-plus-software workflow serving neuroscience research and clinical customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Avrio MedTech

Neurodiagnostic Softwareavriomedtech.com

Avrio MedTech is a French deeptech company commercializing Halyzia®, an AI-powered intracranial EEG visualization and analysis platform for epilepsy research and clinical decision support, serving academic medical centers, hospitals, therapeutic innovators, and EEG equipment providers globally.

What Avrio MedTech does

Avrio MedTech is a French deeptech company founded in August 2023 in Toulouse, commercializing Halyzia®, a software platform for advanced visualization and quantitative analysis of intracranial EEG (iEEG/SEEG) data. The product is built on more than a decade of academic research conducted at CerCo (CNRS), CHU Toulouse, and ENAC, and integrates signal processing, artificial intelligence, and visual analytics to detect epileptic biomarkers — including spikes, ripples (80-200 Hz), and fast ripples (200-600 Hz) — and to compute the Epileptogenicity Index for seizure onset analysis. A core technical differentiator is the patented WALFRID wavelet-based CNN detector for fast-ripples, held under exclusive worldwide rights (PCT/EP2022/079304, US 2024/0398319 A1). Halyzia supports micro/macro electrode recordings up to 32 KHz and combines automatic detection with expert validation workflows and topographic brain mapping.

The company monetizes through three streams: software licensing (subscription/recurring) of Halyzia to research institutions, hospitals and clinics; professional services including quantitative iEEG analysis, custom Clinical Decision Support System development, protocol writing, and project management; and technology integration / white-label modules for EEG equipment providers. Go-to-market combines product-led growth via a free trial download from the website, direct enterprise sales for hospitals and therapeutic innovators, and a channel partnership with FHC Inc. announced in January/February 2025. Customer segments are verticalized: researchers and clinicians (primary), therapeutic innovators (drug developers, neuromodulation, thermo-coagulation), and EEG equipment providers. Named customers and partners include NYU Grossman School of Medicine, CHU de Toulouse, Grenoble University Hospital, CerCo (CNRS), Hôpital Fondation Adolphe de Rothschild, and FHC Inc.

Avrio is a privately held SAS (Société par Actions Simplifiée) with SIREN 978328037, headquartered at the B612 innovation center in Toulouse Aerospace, with an approximately 10-person multidisciplinary team led by co-founders Karine Seymour (CEO, ex-founder of Medexprim), Emmanuel Barbeau (Clinical Lead, CNRS Director of Research), and Christophe Hurter (Data Science Lead, ENAC Professor). To date, funding has been exclusively non-dilutive — Bourse French Tech Emergence (BPI France, 2023), CREALIA Occitanie (2023), DESIRE Eurocluster (2024), and a €75,000 Women TechEU award (January 2025) — with no disclosed institutional venture capital or external revenue figures.

Avrio MedTech firmographics

Firmographics
Name
Avrio MedTech
Legal name
SAS Avrio MedTech
Website
https://avriomedtech.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Short description
Avrio MedTech is a French deeptech company commercializing Halyzia®, an AI-powered intracranial EEG visualization and analysis platform for epilepsy research and clinical decision support, serving academic medical centers, hospitals, therapeutic innovators, and EEG equipment providers globally.
Ownership category
akta.pro rank

Avrio MedTech industry classification

Industry
Product category
Neurodiagnostic Software
NAICS
Computer Systems Design and Related Services (54151)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAKAIAB
Epilepsy & Seizure Disorders
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Intracranial EEG software
  • Epilepsy biomarker analysis
  • Neuroscience visualization tools
  • SEEG data analysis
  • Medical signal processing

Where Avrio MedTech is headquartered

Location

Headquarters

HQ city
Toulouse
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Avrio MedTech business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Software Licensing: Halyzia® software licenses sold to research institutions, hospitals, and clinics. Available for research-use only. Contact-based pricing model.
  2. Professional Services: Quantitative analysis as a service, custom software development, project management, protocol writing, and clinical site contracting services for iEEG research projects.
  3. Technology Integration/White-label: Ready-to-integrate modules for EEG equipment providers and therapeutic innovators. Custom development and white-label options available.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree Trial - Research evaluation license

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Avrio MedTech product offering

Product offering

Core offering

Avrio MedTech develops and sells Halyzia®, a software platform for advanced review and quantitative analysis of intracranial EEG (iEEG/SEEG) recordings. The software combines signal processing, artificial intelligence, and visual analytics to automatically detect epileptic biomarkers (spikes, ripples, fast ripples) and compute the Epileptogenicity Index for seizure onset analysis. It also offers quantitative iEEG analysis services, custom clinical decision support system development, white-label ready-to-integrate modules for EEG equipment providers, and project management services for epilepsy research projects.

Product overview

Avrio MedTech offers Halyzia as its core unified software platform for intracranial EEG (iEEG) quantitative analysis in epilepsy research. The product portfolio includes Halyzia (the main software product), supplemented by professional services such as quantitative iEEG analysis services, custom CDSS development, white-label ready-to-integrate modules for EEG equipment providers, and project management services. The software integrates advanced signal processing, AI-based biomarker detection, and interactive visualization tools.

Differentiator

Problem solved

Functional benefit

Brands

  • Halyzia®: Next generation software for advanced review and quantification of intracranial EEG (iEEG) data. Built on more than 10 years of academic research, Halyzia® integrates advanced signal processing, artificial intelligence, advanced visual analytics, and scalable performance for massive datasets. Features include automatic detection of epileptic spikes and high-frequency oscillations (HFOs), seizure onset analysis with Epileptogenicity Index, and topographic mapping capabilities.

Products and services

  • Halyzia® A next-generation intracranial EEG (iEEG) visualization and quantification software for advanced review and quantitative analysis of iEEG data. Halyzia enables automatic detection of epileptic biomarkers (spikes, ripples, fast ripples) and seizure onset analysis using the Epileptogenicity Index, with interactive topographic brain mapping. Built on more than 10 years of academic research and integrating advanced signal processing, AI, visual analytics, and scalable performance for massive datasets including micro-electrode recordings at up to 32 KHz. Available for research-use only.
  • Quantitative iEEG Analysis Services Expert services including custom iEEG processing pipelines, advanced biomarker extraction, study design and protocol support, data analysis and reporting, and software development and system integration. Services support the full lifecycle from exploratory research to large-scale multicenter studies.
  • Clinical Decision Support System (CDSS) Custom Development Custom design and development services for building dedicated Clinical Decision Support Systems for therapeutic innovations. Integrates clinical, imaging, and electrophysiological data with automated pipelines and intuitive interfaces.
  • Ready-to-Integrate Modules (White-label) White-label modules for EEG equipment providers offering review and monitoring software in iEEG epilepsy monitoring units, enabling advanced analytics capabilities to be embedded in third-party offerings.
  • Project Management Services Comprehensive project management including writing research protocols, sourcing data, contracting with clinical sites, analyzing results, and writing papers for studies involving iEEG signals.

Quantifiable outcome

  • 55% of patients remain seizure-free 5 years after epilepsy surgery when analysis enables surgical decision
  • +1 more outcomes

Companies that use Avrio MedTech

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Avrio MedTech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature7 records

Avrio MedTech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • FHC Inc.coreChannel Partner/ Reseller/ Distributor · 31 January 2025Avrio MedTech and FHC Inc. announced a partnership for distribution of Avrio's innovative sEEG analysis software, Halyzia. FHC integrates Halyzia into their portfolio, providing customers with powerful, modern analytical software alongside their world-class EEG hardware. This partnership extends market reach to epileptic monitoring units globally.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Avrio MedTech competitors and assessment

Company assessment

Direct peers

  • MICROMED: MICROMED (now part of Bittium) provides EEG acquisition and analysis software used in clinical and research settings. It competes with Halyzia in the intracranial and scalp EEG review/quantification market.
  • BESA (BESA GmbH): BESA provides source localization and EEG/MEG analysis software widely used in epilepsy research and clinical neurology. It is comparable to Halyzia as a specialized EEG analysis platform for neuroscience and clinical use.
  • ANT Neuro: ANT Neuro provides EEG and MEG acquisition systems plus analysis software used in neuroscience and clinical applications. It competes with Avrio MedTech in the EEG analysis software category.
  • Blackrock Microsystems: Blackrock Microsystems manufactures neural recording hardware and offers analysis tools used in intracranial EEG research. It is comparable to Avrio MedTech as a provider serving the iEEG research and clinical neuroscience market.
  • Compumedics: Compumedics offers EEG systems including the Curry analysis suite used in clinical epilepsy workflows. It is comparable to Avrio MedTech in serving epilepsy monitoring units with quantitative EEG tools.
  • Persyst: Persyst develops automated EEG analysis software (seizure detection, trending, spike detection) used widely in clinical neurology. It is a direct competitor to Halyzia's automated detection capabilities and is now part of Natus Medical.
  • Brain Products: Brain Products manufactures EEG hardware and offers BrainVision Analyzer for EEG review. It is comparable to Avrio MedTech in the combined EEG hardware-plus-software workflow serving neuroscience research and clinical customers.

Emerging players

  • g.tec medical engineering: g.tec develops brain-computer interface and EEG analysis tools, including real-time signal processing. It overlaps with Halyzia in advanced EEG analysis, with a stronger BCI orientation.
  • Wave Neuroscience: Wave Neuroscience applies EEG-based analytics for neurological and psychiatric conditions. It is an emerging player with adjacent, partially overlapping capabilities to Halyzia's quantitative EEG/biomarker focus.

Broad incumbents

  • Natus Medical: Natus Medical is a broad incumbent in neurodiagnostics, offering EEG, EMG, and ICU monitoring hardware plus software (including the Persyst acquisition). It is comparable to Avrio MedTech as an established player whose portfolio overlaps with Halyzia's analytics focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Avrio MedTech social profiles

Digital presence

Avrio MedTech compliance and trust

Trust signal

Compliance2 records

Avrio MedTech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Avrio MedTech leadership team

Management profile

Number of profiles

Profiles10 records

Avrio MedTech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Avrio MedTech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avrio MedTech

What does Avrio MedTech do?

Avrio MedTech develops and sells Halyzia®, a software platform for advanced review and quantitative analysis of intracranial EEG (iEEG/SEEG) recordings. The software combines signal processing, artificial intelligence, and visual analytics to automatically detect epileptic biomarkers (spikes, ripples, fast ripples) and compute the Epileptogenicity Index for seizure onset analysis. It also offers quantitative iEEG analysis services, custom clinical decision support system development, white-label ready-to-integrate modules for EEG equipment providers, and project management services for epilepsy research projects.

Is Avrio MedTech a public or private company?

Avrio MedTech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Avrio MedTech founded?

Avrio MedTech was founded in 2023. It employs 11 to 50 people.

Where is Avrio MedTech based?

Avrio MedTech is headquartered in Toulouse, France, in the Europe region.

How does Avrio MedTech make money?

Three revenue lines are on record. Software Licensing is the primary driver. The others are professional Services and technology Integration/White-label.

Who are Avrio MedTech's main competitors?

Direct peers on record are MICROMED, BESA (BESA GmbH), ANT Neuro, Blackrock Microsystems, Compumedics, Persyst and Brain Products. Emerging players are g.tec medical engineering and Wave Neuroscience. Natus Medical is listed as a broad incumbent.

Does Avrio MedTech have an API?

No public API is recorded for Avrio MedTech.

What industry is Avrio MedTech in?

Avrio MedTech's product category is Neurodiagnostic Software. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLAKAIAB, Epilepsy & Seizure Disorders. Its NAICS code is 54151 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales